Abnormal Pap Smear Results? Here’s What To Do Next

New Post Public Reply Private Reply Replies (0) Message Board
ziffytech07
343
Pap test or Pap smear is an examination carried out to determine if a woman has cervical cancer. The test looks for the presence of cancerous and precancerous cells on your cervix. Your cervix is an opening of your uterus.

Detecting cancerous cells early with a Pap test gives you a greater chance to fight the disease successfully. A Pap test can detect changes in your cervical cells that can increase the likelihood of developing cervical cancer. Detecting these abnormal cells early is vital in stopping the possibility of cervical cancer.

Women between the ages of 21 to 29 should have a pap test every three years. Women between 30 to 65 should have them combined with an HPV test (Human papillomavirus test) every five years. Women with certain medical conditions with a history of cervical cancer, HIV/AIDS, or those who have a weakened immune system will need more frequent tests.

Why is the Pap test done?

We carry the Pap test out for the following purposes:-

Screen and diagnose precancerous cells present in your cervix.
Screen and diagnose precancerous cells present in your vagina
Diagnose infection or inflammation in the lower reproductive system.
Follow-up tests or monitoring tests after precancerous cells have been found during previous Pap tests.
Determine if the abnormal cells or cancer cells have returned after treatment.
During your Pap test, the best gynecologist in Pune will take samples from your vagina with the help of a spatula to scrape samples from the vagina. They place the collected samples in a special liquid. The sample sent to a laboratory for analysis. Tests results are available after a week or two of your Pap test.

What the results of a Pap test mean?

Pap tests are classified into abnormal results or normal results. Normal results are also called negative results. It means that no abnormal cells were found and you are cancer-free.

Abnormal pap test results do not always indicate cancer or precancerous cells. Abnormal cells can become normal on their own or can be cancerous if left untreated. Abnormal cells can be classified into:-

Squamous cell collected from the surface of the cervix or vagina
Glandular cells collected from inside your cervical canal.
What causes changes?

Abnormal pap test is usually caused by certain types of HPV. HPV is a virus that causes cervical cancer. HPV is sexually transmitted infected. Usually, the HPV goes away on its own. But cells infected with the HPV virus can become precancerous. Changes in cervical cells can also be caused by:-

Viral, bacterial or yeast infection
Swelling or tenderness
Noncancerous growths such as polyps or cysts.
What happens if your pap test results are abnormal?

If your Pap test results are abnormal the best gynecologist in Pune may recommend a colposcopy. The procedure is similar to the Pap test. During the procedure, your gynecologist will use a magnifying lens to look for abnormal cells. Acetic acid will be used during the procedure will turn abnormal cells white. Once the abnormal cells are found your gynecologist will perform a biopsy where small tissue is taken for further testing.

Treatment options after abnormal pap test results?

After colposcopy, the gynecologist near me will explain the results of your tissue sample. The changes can be low grade, your gynecologist may adopt a wait and watch approach. For moderate to high-grade changes, the doctor may evaluate more options that may include removing cervical tissues.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 4

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 8

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Boost for Inseego as George Mulhern Joins Board

Updated Category News Views 140

Inseego Welcomes George Mulhern to Its Board of Directors Inseego Corp. (Nasdaq: INSG) is thrilled to announce the appointment of George Mulhern, a distinguished leader in the wireless technology sector, to its Board of Directors. With a profound background in developing and steering wireless tech companies, Mr. Mulhern has most recently held the position of Senior Vice...

Continue Reading
Economic Outlook Raises Concerns of Inflation Under Trump

Updated Category News Views 128

Increased Economic Concerns with Trump's Return Recent findings reveal that economists are increasingly worried about the potential return of former President Donald Trump and its effects on inflation and federal deficits. Survey Findings on Inflation and Economic Policies A survey conducted by a group of economists indicates a majority foresee higher inflation and...

Continue Reading
Join the Class Action Against Rocket Pharmaceuticals Today

Updated Category News Views 134

Join the Class Action Against Rocket Pharmaceuticals Investors are being called to participate in a class action lawsuit concerning Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). This lawsuit is aimed at recovering losses incurred by shareholders due to alleged securities fraud that impacted the company's financial standing during a specified timeframe. Understanding the...

Continue Reading
Nipocalimab Receives Priority Review from U.S. FDA for gMG

Updated Category News Views 297

Nipocalimab Secures U.S. FDA Priority Review Status Johnson & Johnson (NYSE: JNJ) has exciting news regarding its investigational drug, Nipocalimab. The U.S. Food and Drug Administration (FDA) has granted Priority Review designation for Nisocalimab as a treatment for generalized myasthenia gravis (gMG) in patients with specific autoantibodies. This important milestone...

Continue Reading
Navigating the Canadian Multifamily Landscape: Supply and Demand

Updated Category News Views 89

Understanding Canada's Multifamily Market Trends In recent times, the Canadian multifamily housing market has exhibited some intriguing trends, particularly concerning rent growth and vacancy rates. As highlighted in the latest report from Yardi Canada, the market showcases a scenario where rent growth is slowing, while vacancies remain low. This situation reflects the...

Continue Reading